In 2025, expect to see a continued emphasis on minimizing the environmental footprint of congress booths without compromising ...

AbbVie and Simcere Zaiming have announced a partnership worth over $1bn to develop an investigational drug candidate for ...

Biogen and Eisai have announced that the US Food and Drug Administration (FDA) has accepted a Biologics License Application ...

Regeneron recently presented five-years results from the phase 3 EMPOWER-Lung 1 trial of Libtayo as a first-line treatment ...

In a rapidly evolving industry, staying ahead means embracing new tools thoughtfully. We're setting the gold standard by ...

In her first Ask Alex article of the year, Scientific Director, Dr Alexandra Loveday explores the ways our expert writers ...

In her latest Ask Alex article, Principal Medical Writer, Dr Alexandra Loveday explores modular content and whether it holds ...

Social 360 Social360 are a specialist social media monitoring provider. We combine our own search technology with comms experienced editors, who produce actionable reports at a frequency an in-house ...

Eli Lilly and Alchemab Therapeutics have partnered to develop new therapies for amyotrophic lateral sclerosis (ALS). The ...

We work with biotech and pharma teams who prioritise the patient experience and want to ensure their engagement throughout a drug’s lifecycle, from pre-phase 1 to the real world. We specialise in ...

Vivactis Global Health The Vivactis Group is one of the world’s largest independent healthcare consulting, communications, and marketing networks. Vivactis Global Health draws upon their rich local ...